How do anticoagulants affect the management of patients with chronic lymphocytic leukemia (CLL) at risk of thromboembolic complications?
Gaurav ChauhanContributor
How do anticoagulants affect the management of patients with chronic lymphocytic leukemia (CLL)?
Share
Anticoagulants are crucial for CLL patients at risk of thromboembolic events by reducing blood clot formation, thereby managing and mitigating the risk of strokes and heart attacks.